Psyence Biomedical Ltd. - Ordinary Shares (PBM)

Psyence Biomedical Ltd. is a leading biotechnology company focused on harnessing the therapeutic potential of psychedelics to develop innovative treatments for mental health conditions and other ailments

The company is dedicated to conducting research and clinical trials to better understand the efficacy and safety of its psychedelic compounds, aiming to advance the field of mental health care. Through the development of proprietary formulations and treatment protocols, Psyence strives to create evidence-based solutions that can improve the quality of life for patients suffering from conditions such as depression, anxiety, and post-traumatic stress disorder.